J.B. Chemicals & Pharmaceuticals releases Q2 FY26 earnings, open offer details

J.B. Chemicals & Pharmaceuticals Limited announced on November 12, 2025, the availability of an audio recording of its investors/analysts call. The call, held on the same date, discussed the company's results and developments for the second quarter ended September 30, 2025. This disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the recording is accessible via a provided link on the company's website.

Concurrently, the company issued newspaper advertisements on November 12, 2025, concerning the recommendations of the Committee of Independent Directors on the Open Offer made by Torrent Pharmaceuticals Limited. This advertisement, published in Financial Express, Jansatta, and Navshakti, relates to Regulation 26(7) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Furthermore, J.B. Chemicals & Pharmaceuticals Limited also published newspaper advertisements for its financial results for the quarter and half year ended September 30, 2025. These results were published in Business Standard and Sakal editions on November 12, 2025, in compliance with Regulation 47(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.